ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Gemphire Therapeutics Inc.
0.3000
0.0000
成交量：
- -
成交額：
- -
市值：
446.17萬
市盈率：
-0.31
高：
0.3000
開：
0.3000
低：
0.3000
收：
0.3000
52周最高：
1.49
52周最低：
0.2380
股本：
1,487.24萬
流通股本：
1,028.40萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.9678
每股收益(LYR):
-1.7121
淨資產收益率：
-280.97%
總資產收益率：
-44.90%
市淨率：
2.27
市盈率(LYR):
-0.18
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Gemphire Therapeutics Inc.
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.gemphire.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Gemphire Therapeutics Inc.於2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)這個名字註冊成立。公司是一家臨床階段的生物製藥公司，致力於將用於治療血脂異常，即一種會增加威脅生命的心血管疾病風險的嚴重的疾病療法的研究開發和商業化。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GEMP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"GEMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","market":"US","secType":"STK","nameCN":"Gemphire Therapeutics Inc.","latestPrice":0.3,"timestamp":1577739600000,"preClose":0.3,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":10283980,"shares":14872411,"eps":-0.967778,"marketStatus":"已收盤","change":0,"latestTime":"12-30 16:00:00 EST","open":0.3,"high":0.3,"low":0.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.967778,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":5,"symbolChange":{"newSymbol":"NRBO","executeDate":"2019-12-31"},"adr":0,"adrRate":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.3,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","floatShares":10283980,"roa":"-44.90%","roe":"-280.97%","lyrEps":-1.712137,"shares":14872411,"dividePrice":0,"high":0.3,"amplitude":0,"preClose":0.3,"low":0.3,"week52Low":0.238,"pbRate":"2.27","week52High":1.485,"institutionHeld":0,"latestPrice":0.3,"eps":-0.967778,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.967778,"open":0.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GEMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-31","symbol":"GEMP","oldSymbol":"GEMP","newSymbol":"NRBO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1577768400000},{"market":"US","date":"2019-12-31","symbol":"GEMP","type":"split","dateTimestamp":1577768400000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2019-08-09","symbol":"GEMP","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565323200000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2019-05-09","symbol":"GEMP","fiscalQuarterEnding":"2019/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557374400000,"reportTimeType":"","actualEps":-0.27},{"market":"US","date":"2019-03-15","symbol":"GEMP","fiscalQuarterEnding":"2018/12","expectedEps":-0.39,"name":null,"time":"","type":"earning","dateTimestamp":1552622400000,"reportTimeType":"","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GEMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.gemphire.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Gemphire Therapeutics Inc.於2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)這個名字註冊成立。公司是一家臨床階段的生物製藥公司，致力於將用於治療血脂異常，即一種會增加威脅生命的心血管疾病風險的嚴重的疾病療法的研究開發和商業化。","exchange":"NASDAQ","name":"Gemphire Therapeutics Inc.","nameEN":"Gemphire Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":null}}